[Value of prostaglandin E1 in the treatment of cyanotic congenital heart defects in infants].
D000527:Alprostadil; D006330:Heart Defects, Congenital / Q000188:drug therapy*; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy; D007223:Infant; D007231:Infant, Newborn; D011458:Prostaglandins E / Q000627:therapeutic use*; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*; D011651:Pulmonary Artery / Q000002:abnormalities; D014188:Transposition of Great Vessels / Q000188:drug therapy
D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D000527:Alprostadil
Znaczenie prostaglandyny E1 w leczeniu siniczych wad wrodzonych serca u noworodków i niemowlat.